Journal
JOURNAL OF SEX & MARITAL THERAPY
Volume 31, Issue 3, Pages 257-262Publisher
BRUNNER-ROUTLEDGE
DOI: 10.1080/00926230590513474
Keywords
-
Categories
Ask authors/readers for more resources
Antidepressants, especially serotonin reuptake inhibiting agents, are associated with sexual dysfunction. The newest drug of this class, escitalopram, claims greater tolerability than older alternatives. This study evaluated patient experiences with switching from one serotonin enhancing antidepressant to escitalopram in individuals who already were complaining of antidepressant-induced sexual dysfunction. We found that 68.1% of patients experienced improvement with their sexual function. The ability to obtain a satisfactory clinical response at relatively low doses may explain this finding. We performed gender, phase of sexual response, and dose analyses. This article discusses results and significance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available